BOSTON, Oct. 21 - As traditional robotics approaches the limits of its usefulness in drug discovery, biotech and pharma companies, beset by shrunken pipelines and pressed for time, have set their sites on a new breed of lab automation.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.